Schering AG
Schering AG is a German firm founded in 1851, based in Wedding, with 10,000+ employees. Its firmographic profile references Bayer's healthcare, nutrition, and high-tech materials businesses. Operational data, products, customers, and pricing are unavailable in the supplied source material.
- Company typePrivate
- Founded1851
- HeadquartersWedding, Germany
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Schering AG firmographics
Firmographics- Name
- Schering AG
- Website
- https://schering.xyz
- Company type
- Private
- Founded year
- 1851
- Headcount range
- 5,001–10,000 employees
- Short description
- Schering AG is a German firm founded in 1851, based in Wedding, with 10,000+ employees. Its firmographic profile references Bayer's healthcare, nutrition, and high-tech materials businesses. Operational data, products, customers, and pricing are unavailable in the supplied source material.
- Ownership category
- akta.pro rank
Where Schering AG is headquartered
LocationHeadquarters
- HQ city
- Wedding
- HQ country
- Germany
- HQ region
- Europe
Markets served
Schering AG business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Schering AG product offering
Product offeringCore offering
Schering AG is described in the firmographic record as a global enterprise with core competencies in health care, nutrition, and high-tech materials. The available source material does not enumerate specific products, services, therapeutic areas, or SKU-level offerings. The company's official website (schering.xyz) was unreachable at time of capture. A 1999 acquisition of Diatide is the only concrete commercial activity documented in the source.
Differentiator
Problem solved
Functional benefit
Companies that use Schering AG
Customer profileIdeal customer profiles1 record
Schering AG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Schering AG competitors and assessment
Company assessmentBroad incumbents
- Sanofi: Sanofi is a broad incumbent peer as a major European-headquartered pharmaceutical preparation manufacturer with overlapping franchises in specialty care, neurology, and immunology that historically competed head-to-head with Schering AG products.
- Pfizer: Pfizer is a broad incumbent peer as one of the world's largest pharmaceutical preparation manufacturers, competing in the same prescription pharmaceutical categories and global commercial channels as the historical Schering AG.
- Novartis: Novartis is a broad incumbent peer as a global pharmaceutical preparation manufacturer with comparable scale, a similar European heritage, and overlapping therapeutic-area exposure (specialty pharma, women's health, neurology) to Schering AG's historical portfolio.
- Roche: Roche is a broad incumbent peer as a global pharmaceutical preparation manufacturer with strong franchises in specialty therapeutics and diagnostics that historically overlapped with Schering AG's therapeutic areas (notably neurology, oncology, and imaging agents).
- AstraZeneca: AstraZeneca is a broad incumbent peer as a global pharmaceutical preparation manufacturer with a comparable European footprint and overlapping therapeutic areas (oncology, cardiovascular, respiratory) where Schering AG historically competed.
- GlaxoSmithKline (GSK): GSK is a broad incumbent peer as a global pharmaceutical preparation manufacturer with overlapping European and global commercial reach, and historical competition with Schering AG in respiratory, neurology, and consumer health adjacencies.
- Bayer AG: Bayer is the most directly comparable peer because it acquired the historical Schering AG in 2006 and now owns and operates the legacy Schering product portfolio across pharmaceuticals, consumer care, and crop science. Any current Schering AG entity is either a residual of that combination or a name-conflict case for Bayer.
Direct peers
- Merck KGaA: Germany-based Merck KGaA is a direct peer as a major German pharmaceutical and life-sciences manufacturer with overlapping capabilities in pharmaceutical preparation manufacturing, specialty therapeutics, and healthcare-aligned chemistry, serving a comparable European institutional customer base.
- Boehringer Ingelheim: Boehringer Ingelheim is a comparable privately held German pharmaceutical company of similar scale, operating in prescription pharmaceutical preparation manufacturing across respiratory, cardiometabolic, and specialty therapy areas — directly paralleling Schering AG's historical positioning.
- Bayer HealthCare (historical Schering integration): Bayer's former Schering-integrated pharmaceuticals division is the most direct functional peer: it operates the products, brands, and pipeline that originated with Schering AG and represents the going-concern successor to the historical Schering AG business.
Market position
Customer concentration
Schering AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
Schering AG leadership team
Management profileNumber of profiles
Schering AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Schering AG M&A and investment
M&A and investmentM&A1 record
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Schering AG
What does Schering AG do?
Schering AG is described in the firmographic record as a global enterprise with core competencies in health care, nutrition, and high-tech materials. The available source material does not enumerate specific products, services, therapeutic areas, or SKU-level offerings. The company's official website (schering.xyz) was unreachable at time of capture. A 1999 acquisition of Diatide is the only concrete commercial activity documented in the source.
Is Schering AG a public or private company?
Schering AG is a private company. It is classified as corporate owned.
When was Schering AG founded?
Schering AG was founded in 1851. It employs 5,001 to 10,000 people.
Where is Schering AG based?
Schering AG is headquartered in Wedding, Germany, in the Europe region.
Who are Schering AG's main competitors?
Broad incumbents on record are Sanofi, Pfizer, Novartis, Roche, AstraZeneca, GlaxoSmithKline (GSK) and Bayer AG. Direct peers are Merck KGaA, Boehringer Ingelheim and Bayer HealthCare (historical Schering integration).
Does Schering AG have an API?
No public API is recorded for Schering AG.